A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study
April 24, 2017
| By Sabrina Richards / Fred Hutch News Service
A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.
International team of scientists show how real-time sequencing and data-sharing can help stop the next outbreak
April 12, 2017
| By Mary Engel / Fred Hutch News Service
An international team of scientists analyzed 1,610 Ebola virus genomes for the most comprehensive look to date at the how the 2013-2016 epidemic spread, proliferated and declined across the three West African countries most affected.
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
April 4, 2017
| By Rachel Tompa / Fred Hutch News Service
A major roadblock to adopting T-cell therapy to solid tumors is what’s known as the tumor microenvironment, the local milieu of non-cancerous cells and molecules in and around the tumor. Fred Hutch researcher Dr. Kristin Anderson and her colleagues in Dr. Phil Greenberg's lab are working to overcome those barriers.